Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
| Image |  |
|---|---|
| Description | scientific article published on 10 February 2017 |
| Author/s |
author: Dana Horáková Alessandra Lugaresi Neil Scolding Eva Havrdová Mark Slee Steve Vucic Vincent van Pesch Tjalf Ziemssen Vilija Jokubaitis Claire M Rice Pamela A. McCombe Pierre Duquette Maria Trojano Raed Alroughani J William L Brown Guillermo Izquierdo Patrizia Sola Pierre Grammond Helmut Butzkueven Tomáš Kalinčík Eugenio Pucci Michael Hutchinson Michael Barnett Alexandre Prat José Luis Sánchez Menoyo Raymond Hupperts |
| Publication date | February 11, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |